SIRT6 and neoplasm: In non-small cell lung cancer (NSCLC), the inhibition of proliferation mediated by SIRT6 is the result of the suppression of Twist1 expression, a key player involved in two different tumor processes such as metastatization and epithelial-mesenchymal transition (EMT) [62].